γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
γ-分泌酶抑制剂联合BCMA嵌合抗原受体T细胞免疫疗法治疗复发或难治性多发性骨髓瘤患者：一项I期首次人体试验
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(23)00246-2
Cowan, Andrew J; Pont, Margot J; Sather, Blythe D; Turtle, Cameron J; Till, Brian G; Libby, Edward N 3rd; Coffey, David G; Tuazon, Sherilyn A; Wood, Brent; Gooley, Ted; Wu, Vicky Q; Voutsinas, Jenna; Song, Xiaoling; Shadman, Mazyar; Gauthier, Jordan; Chapuis, Aude G; Milano, Filippo; Maloney, David G; Riddell, Stanley R; Green, Damian J
T细胞
多发性骨髓瘤
信号转导
T细胞
骨髓瘤
细胞生物学
免疫/内分泌
